bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester) for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Jul 2025: Trial registered, NCT07097506
  2. 26 Sep 2025: Trial started, NCT07097506

The trials

NCT07097506: Effect of Ketone Esters on Liver Fat Content and Metabolic Function

State
Under way
Phase
Phase 2
People
40 planned
Started
26 Sep 2025
Primary completion
31 Jul 2027
Arms
C8 ketone di-ester
Results
None posted
  1. 31 Jul 2025: Trial registered
  2. 26 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.